(Q40867552)

24 September 2017

1 reference

title

Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment (English)

1 reference

24 September 2017

1 reference

R H Wiesner

1

1 reference

24 September 2017

J Ludwig

2

1 reference

24 September 2017

R A Krom

3

1 reference

24 September 2017

J E Hay

4

1 reference

24 September 2017

B van Hoek

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

68

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

69-79

1 reference

Rejection in liver transplantation

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The first 100 liver transplantations at the Mayo Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Hepatic endothelial cells. Targets in liver allograft rejection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Patterns of graft rejection following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Terminology of hepatic allograft rejection (glossary)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Persistent centrilobular necroses in hepatic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. The Liver Transplantation Database (LTD) Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The first 100 liver transplants at UCLA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

HLA compatibility and different features of liver allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Pathologic analysis of liver transplantation for primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Recent developments in liver transplantation. Lessons from a 5-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

OKT3 prophylaxis in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Liver transplantation in 100 children: Cambridge and King's College Hospital series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The impact of liver reductions in pediatric liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The pediatric nephrologist's dilemma: growth after renal transplantation and its interaction with age as a possible immunologic variable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Liver transplantation with use of cyclosporin a and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Cyclosporine-associated chronic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Treatment of acute rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

RS-61443--a phase I clinical trial and pilot rescue study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

Evolution of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Resistant hepatic allograft rejection successfully treated with cyclophosphamide and plasmapheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960022-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)60022-6

1 reference

24 September 2017

1 reference